FDA Investigator Darin S Wiegers

Darin S Wiegers has inspections in 10 countries as of 27 Oct 2023. Darin S Wiegers has collaborated with a combinined 5116 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
259
Last Inspection Date:
27 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, India, Romania, France, Malaysia, Thailand, Mexico, Germany, Turkey, Serbia
Co-Investigator(s):
A Williams, Aaron L Morris, Abby E Pelletier, Alan M Stevens, Alan R Condon, Alanna Lmussawwir Bias, Alfred P Pistorio, Alice C Silva, Alissa E Berryman, Alysia M Salonia, Amber G Wardwell, Amy C Jordan, Amy M Cramer, Ana P Barido, Andre S Lamontagne, Andrew M Barlow, Anthony C Warchut, Anthony E Keller, RPh, Anthony N Onianwa, Anthony P Costello, Anthony W Thomas, Arie C Menachem, Ashley M Whitehurst, Asia D Clark, Babatunde D Babalola, Barbara D Wright, Bo Chi, PhD, Bogdan Kurtyka, Bradford L Swanson, Bradley D Newsad, Brandy D Brown, Brandy L Couillard, Brenda P King, Brenna L Macdowell, Brinda Dass, Bruce R Ota, Byungja E Marciante, Camerson E Moore, Carla C Cummins, Carla C Tuite, Cassandra L Abellard, Celia N Cruz, Charles A Snipes, PhD, Charles R Bonapace, PhD, Charles R Clavet, Charlotte Hinkle, Chiang Syin, PhD, Christina Capacci Daniel, PhD, Christine L Williams, Christine M Parmentier, Christine M Smith, Christopher A Demitrius, Christopher J Cruciotti, Christopher Janik, Christopher K Vantwuyver, Christopher M Elliott, Chunsheng Cai, PhD, Clinton V Giustra, Constance Desimone, Courtney N Long, Craig T Rybus, Crystal Nevins, Cynthia F Kleppinger, MD, Cynthia Jim, CSO, Cynthia Whitmarsh, Danielle S Pearson, Darin S Wingers, Daryl A Dewoskin, David J Cummings, David J Feria, David M Lamoureux, David P Vanhouten, David Van Houten, Dawn C Olenjack, Dawn Hraswell, Dawn L Wydner, Dawn M Braswell, Dean R Rugnetta, Denise M Visco, Investigator, Diane C Thibodeau, Diane M Prince, Dien N Nguyen, Dominic R Frasca, Donahue, Dorothy W Lee, Douglas Florentino, Douglas S Joslin, Dr. Abhijit Raha, PhD, Dr. Mark J Seaton, PhD, Dr. Robert C Horan, MD, Dr. Zhou Chen (nmi), MD PhD, Edmund F Mrak, Jr, Edward J Janik, Elise L Mcdevitt, Elizabeth B Griffin, Elizabeth Ll Edwards, Elmiloudi M Sarhrani, Emily J Schramm, Eric C Schmitt, Erich P Garger, Erik W Koester, Frank J Koch, Gabrielle J Swain, Garry H Stewart, Gary J Hagan, Gary S Hagan, George T Allen, Jr, Gerard D Difiore, Guozhou Mo, Hang N Guo, Harlan J Howard, Harperd, Hien Albright, Irons, James H Tanner, James P Finn, James W Whitney, Jamie S Mathews, Janete F Guardia, Jason A Rossi, Jason D Tenney, Jay M Patria, Jayaleka J Amarasinghe, Jeffery A Hangartner, Jeffrey J Thibodeau, Jeffrey S Buckser, Jessica D Spellman, Jessica I Newman, Joao Pedras Vasconcelos, PhD,, John A Sciacchitano, John L Zaccone, John P Mistler, John P Shelton, John R Carlson, John S Hartford, Jonah S Ufferfilge, Jonathan B Lewis, Jonathan G Matrisciano, Jonee J Mearns, Joppie, Jose A Torres, Joseph B Cascio, Joseph C Teixeira, Joseph T Frost, Joshua L Gibbs, Joyce A Kellett, Justin A Boyd, Justine M Corson, Karen Mcnabb Noon, Kathleen E Mcafoose, Kenneth H Williams, Kent A Conforti, Kimberly M White, Lauren B Brown, Lauren Iacono Connors, PhD, Lauren M Lawrance, Lauren M Mclaughlin, Laurie B Frazier, LCDR Debra Emerson, Leo B Zadecky, Li Yun Huang, Ling Yang, Lisa D Cash, Liz M Otero, Lorayne A Mcguinness, Lori A Holmquist, Louis Christy, Lucie Yang, M Patriciaurphy Murphy, Malini Wileman, PhD, Marcelo O Mangalindan, Jr, Marcia M Laughrey, Margaret E Walsh, Margaret M Sands, Marion W Nadeau, Mariza M Jafary, Mark E Farrell, Mark K Tseng, Mark R Mcclain, Martin J Guardia, Mary Jeanet Mcgarry, Mary R Hole, Maryam Tabatabaie, Matthew C Watson, Maura Rooney, Max Lager, Maya M Davis, Megan A Haggerty, Megan A, Haggerty, Michael G Mayfield, Michael P Anthony, Michael P Sweeney, Michael Serrano, Michelle L Johnson, Michelle M Noe, Michelle M Noe Varga, Mihaly S Ligmond, Min Lu, Mpris Inspector, Nabil Nakhoul, Nasser Yazdani, Nassim Ben Makhlouf, Nealie C Newberger, Nichole B Murphy, Nina Yang, Osama A Khatib, Pamela L Ogonowski, Paraluman S Leonin, Patrick C Klotzbuecher, Paul L Bellamy, Paul M Gelfand, Paul P Geraci, Paula M Laplant, Pauline N Logan, Perry H Gambrell, Peter R Lenahan, Philip H Lafleur, Philip Kreiter, Phillip E Mclaughlin, Prabhu P Raju, Rachel M Skeete, Ramcharan S Khalsa, Ramon E Martinez, Rapti D Madurawe, Rebecca A Coleman, Rebecca T Davis, Richard A Abate, Richard F Hapke, Richard L Licari, Robert D Ogan, Robert E Teel, Robert J Martin, Robert Mo Brien, Rory K Geyer, Rupa Pradhan, Ryan J Mcgowan, Samina S Khan, Sandra P White, Sara M Onyango, Scott B Laufenberg, Sean M Tessicini, Sean R Marcsisin, Seth A Mailhot, Sharmista Chatterjee, Shawn M Bogdan, Shirley S Wen, Simone E Pitts, Slater K Bartlett, Stacey S Degarmo, State Agency, Stephanie M Roberts Pedotti, Stephanie Mangigian, MS/OSH, RN, Stephen C King, Stephen C Smith, Stephen R Souza, Sunita Pandey, Susanne M Richardson, MSc RAC ELS, Suwaskie S Smith, Suzanne M Healy, Sylvia A Craven, Tamara S Rosbury, Tawny L Colling, Teddy Tom, Terry C Kimball, Thomas B Gilmore, Thomas Cote, Thomas J Arista, Thomas J Murphy, Thomas Siebertz, Thomas W Nerney, Timothy M Glod, Tina A Desorcy, Todd D Alspach, Troy R Petrillo, Tyanna N Hadley, Victor J Gangi, Victoria D'addeo, Victoria M Daddeo, Victoria Rosales, Victoria Taylor, Vioela J Caze, Wendy A Johnecheck, William K Dagley, William S Boivin, Xiaokuang Lai, PhD, Yong Hu, Ze Peng, Zhongren Wu

Darin S Wiegers's Documents

Publish Date Document Type Title
April, 2020 EIR Bristol Myers Squibb - EIR, 2020-04-22
February, 2016 EIR Caroline E. Lyon, M.D. - EIR, 2016-02-11
February, 2015 EIR Vertex Pharmaceuticals Incorporated - EIR, 2015-02-17
January, 2004 FDA 483 Access CardioSystems - Form 483, 2004-01-30
February, 2012 FDA 483 Perceptive Informatics LLC (d.b.a. Calyx) - Form 483, 2012-02-23
July, 2013 FDA 483 Charles River Laboratories, Inc. - Form 483, 2013-07-12
October, 2013 FDA 483 Response Perceptive Informatics LLC (d.b.a. Calyx) - Form 483R, 2013-10-24
May, 2005 FDA 483 Boston Scientific Corporation - Form 483, 2005-05-20
August, 2015 EIR Perceptive Informatics LLC (d.b.a. Calyx) - EIR, 2015-08-13
October, 2018 EIR Pfizer Laboratories Div Pfizer Inc - EIR, 2018-10-05
May, 2010 FDA 483 Mustafa Ozguroglu - Form 483, 2010-05-14
December, 2021 EIR Jawahar L. Taunk, M.D. - EIR, 2021-12-09
May, 2016 FDA 483 Robert D. Winslow, M.D. - Form 483, 2016-05-26
April, 2016 EIR Labcorp Bedford LLC. - EIR, 2016-04-29
October, 2013 FDA 483 Perceptive Informatics LLC (d.b.a. Calyx) - Form 483, 2013-10-04
December, 2015 EIR Perceptive Informatics LLC (d.b.a. Calyx) - EIR, 2015-12-03
June, 2016 EIR Perceptive Informatics LLC (d.b.a. Calyx) - EIR, 2016-06-24
August, 2019 FDA 483 Ian E. Krop, M.D. - Form 483, 2019-08-26
March, 2009 FDA 483 ONC Solutions Incorporated - Form 483, 2009-03-23
June, 2018 FDA 483 Pfizer Laboratories Div Pfizer Inc - Form 483, 2018-06-21
April, 2016 FDA 483 Labcorp Bedford LLC. - Form 483, 2016-04-29
June, 2018 EIR Pfizer Laboratories Div Pfizer Inc - EIR, 2018-06-21
January, 2004 EIR Access CardioSystems - EIR, 2004-01-30
October, 2009 FDA 483 Abbott Laboratories - Form 483, 2009-10-13
October, 2013 EIR Perceptive Informatics LLC (d.b.a. Calyx) - EIR, 2013-10-04
January, 2016 FDA 483 Caroline E. Lyon, M.D. - Form 483, 2016-01-06
April, 2009 FDA 483 ATC Technologies, Inc. - Form 483, 2009-04-09
February, 2012 EIR Perceptive Informatics LLC (d.b.a. Calyx) - EIR, 2012-02-23
September, 2009 FDA 483 Multi-Med, Inc. - Form 483, 2009-09-11
January, 2017 EIR Pfizer Laboratories Div Pfizer Inc - EIR, 2017-01-12
June, 2011 EIR Pfizer Laboratories Div Pfizer Inc - EIR, 2011-06-09
February, 2014 FDA 483 Response Thomas E. Flynn, M.D. - Form 483R, 2014-02-26
April, 2005 FDA 483 Boston Scientific Corporation - Form 483, 2005-04-07
April, 2016 FDA 483 Desiree NMI Medeiros, M.D. - Form 483, 2016-04-01
December, 2007 FDA 483 Spectra Medical Devices, LLC - Form 483, 2007-12-14
February, 2016 EIR Southern New Hampshire Medical Center IRB - EIR, 2016-02-25
December, 2009 FDA 483 J & S Medical Associates, Inc. - Form 483, 2009-12-03
April, 2016 EIR Desiree NMI Medeiros, M.D. - EIR, 2016-04-01
February, 2017 FDA 483 Karyopharm Therapeutics Inc. - Form 483, 2017-02-08
April, 2008 FDA 483 Boston Scientific Corporation - Form 483, 2008-04-18
September, 2009 FDA 483 Covance Research Products Inc. - Form 483, 2009-09-23
July, 2013 EIR Charles River Laboratories, Inc. - EIR, 2013-07-12
October, 2018 EIR AMAG Pharmaceuticals, Inc. - EIR, 2018-10-22
December, 2021 FDA 483 Jawahar L. Taunk, M.D. - Form 483, 2021-12-09
November, 2007 FDA 483 Global Protection Corporation - Form 483, 2007-11-07

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more